Small Molecules

What can be done to improve the quality of APIs sourced from China and India?

A novel small molecule aims to tackle both Alzheimer’s disease and Dravet syndrome.

Bernhardt Trout talks about the ways in which continuous manufacturing can meet the needs of the ever-changing pharmaceutical industry.

How are reactor technologies supporting pharma companies?

Is the industry ready for continuous manufacturing?

Cures for all presents a real focus for the next decade – but companies must be rewarded for their work.

How will the adoption of novel approaches to the development of excipients help overcome the challenges of poorly soluble APIs?

After a vibrant year of advances in pharmaceutical development and manufacturing technologies, we present The Medicine Maker 2019 Innovation Awards.

Hovione’s New Jersey-based site has provided process development and small volume API manufacturing since 2002.

The reported benefits of continuous manufacturing for small molecules over batch manufacturing include accelerated product and process development.